Results 181 to 190 of about 46,025 (225)

Actual status of visitor and telephone restrictions for Japanese psychiatric inpatients: A retrospective observational study

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Aim To clarify the status of visitor and telephone restrictions and the factors associated with these restrictions among patients hospitalized for the treatment of mental disorders. Methods This study included 1,998 patients hospitalized for the treatment of mental disorders at the Department of Psychiatry, Kitasato University Hospital, and ...
Yoshitaka Saito   +4 more
wiley   +1 more source

Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Cannabinoid products are increasingly used worldwide despite limited psychiatric evidence. This narrative review synthesizes preclinical and clinical evidence on cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) to clarify their distinct psychiatric profiles and discuss how current evidence may inform ongoing clinical and ...
Yasuhiro Kishi   +2 more
wiley   +1 more source

Catatonia with prominent psychosocial factors: A case report

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Background Catatonia is a psychomotor syndrome historically linked to schizophrenia but now recognized across diverse psychiatric, medical, and psychosocial contexts. Detailed reports of catatonia arising amid pronounced psychosocial vulnerability remain scarce.
Hiroto Noguchi   +4 more
wiley   +1 more source

Comparison of depressive symptoms and anxious distress between major depressive disorder and bipolar disorder using the CUDOS‐A

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Aim Anxious distress is a clinically important specifier associated with adverse outcomes in mood disorders. This study aimed to compare the prevalence of anxious distress and overall depressive symptoms between patients with major depressive disorder (MDD) and bipolar disorder (BD) using validated self‐report measures.
Kazufumi Oishi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy